Dr. Rejmon Dedaj, MD

Dr. Dedaj practices at Deaconess Midtown Hospital - Outpatient Therapy in Evansville, Indiana.

Dr. Dedaj's NPI, 1124297361, was assigned on February 21, 2008. Dr. Dedaj graduated from Univ Genoa- Fac Med in 2003. Dr. Dedaj holds Kentucky license 46072.

Dr. Dedaj's primary practice is Deaconess Midtown Hospital - Outpatient Therapy, at 600 Mary St, Evansville, IN 47747. The practice phone is (812) 450-3324.

Dr. Dedaj's primary practice is Deaconess Midtown Hospital - Outpatient Therapy in Evansville, Indiana. Dr. Dedaj is also affiliated with Deaconess Midtown Hospital. The medical group on file is Deaconess Health System. Dmand AI also links Dr. Dedaj to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dedaj practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Dedaj's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Dedaj is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Dedaj's licenses on file in 3 states: Kentucky, Indiana and Massachusetts.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pneumonia, pulmonary fibrosis and pulmonary heart disease among the conditions Dr. Dedaj treats.

CMS data shows 2,128 Medicare services from Dr. Dedaj across 25 procedure codes in 2024, for 700 Medicare patients. Medicare paid $162,751 for them.

CMS counts 700 Medicare patients who saw Dr. Dedaj in 2024. The largest group is 65 to 74, with 295 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dedaj's median patient age at 72, with 57% women.

In 2024, Dr. Dedaj wrote 4,829 Medicare Part D claims for 589 patients. CMS names the drug for 4,676 of them, across 53 drugs with 11 or more claims each, at $4,581,972 in total drug cost. In 2023, CMS named 3,667 claims across 46 drugs.

Dr. Dedaj accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Dedaj, published from 2010 to 2018. Dr. Dedaj's most frequent co-author is Deborah Ann Quinn, MD.

CMS Open Payments shows 1,238 general payments to Dr. Dedaj from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. AstraZeneca Pharmaceuticals LP paid the most, $4,140.

Dr. Dedaj graduated from Univ Genoa- Fac Med in 2003.

Dr. Dedaj is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.